Story

Chemours Stock Tumbles After Q2 Earnings Miss, Lowered Full-Year Outlook

ENTHMSVIIDZHZH-TWJAKOHI
Aug 5, 20262 min read
Chemours Stock Tumbles After Q2 Earnings Miss, Lowered Full-Year Outlook
Text size
Background

Shares of The Chemours Company (NYSE: CC) plummeted in morning trading, falling 15.6% to $15.13 after the company reported disappointing second-quarter 2026 financial results and cut its full-year forecast. The chemical maker's performance failed to meet market expectations on both revenue and profit, prompting a significant investor sell-off.

Earnings and Outlook Disappoint

Chemours announced its second-quarter results after the market close of the prior session, revealing a significant miss on key metrics. The company's performance and revised guidance included:

  • Adjusted Earnings: $0.42 per share, below the analyst consensus estimate of $0.50 per share.
  • Revenue: $1.59 billion, missing the consensus forecast of $1.66 billion.
  • Full-Year Guidance: The company trimmed its full-year 2026 adjusted EBITDA forecast to a range of $775 million to $825 million, down from the previous range of $800 million to $900 million.
  • Q3 Outlook: Management guided for third-quarter net sales to be down 5% to flat sequentially, with adjusted EBITDA of only $175 million to $205 million.

Weakness in Key Segment

The weaker-than-expected results were driven by challenges in the company's flagship Thermal & Specialized Solutions (TSS) segment. Net sales for the unit fell 1% year-over-year as volumes declined 4%.

Sample IUX Markets – In-articleAd

Management attributed the decline to softer demand in the residential air-conditioning aftermarket. This represents a normalization from the exceptionally strong sales a year ago, which were driven by channel-fill activity. The company also noted that margin pressure in the segment is not expected to recover until 2027.

Market Context

The steep decline in Chemours' stock was a company-specific event, occurring while the broader U.S. market posted gains. The S&P 500 rose 0.6% and the Dow Jones Industrial Average added 1.1%, underscoring that the sell-off was not driven by macroeconomic headwinds.

Despite the weak results, Chemours announced it would maintain its quarterly dividend, declaring a Q3 2026 payout of $0.0875 per share. The company also noted that it continued to generate cash and reduce debt during the quarter.

Read next

More on Stocks
Back to latest news

LATEST